Come up with a name for your new list and we'll add to it:
ADMA Biologics raised a round of funding on February 14, 2012. Investors include
R&R Acquisition VI.
ADMA is a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases. ADMA…